Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
milrinone (primacor) (1 trial)
cd19 car-t cells (1 trial)
Cardiac Output, Low (Phase 3)
Leukemia (Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Syndrome (Phase 3)
Trials (2 total)
Trial APIs (2 total)